Blood Cancer Therapeutics Laboratory
2018 Blood Cancer Therapeutics group L-R: A/Prof Jake Shortt, Dr Jonathan Wong, Dr Zahra Sabouri-Thompson, Dr Gareth Gregory, Ms Belinda Maher, Dr Daniella Brasacchio, Dr Mark Waltham, Ms Maria Docanto, Dr Greg Corboy, Dr Danielle Oh, Dr Josh Casan
Blood Cancer Therapeutics Laboratory's research seeks to evaluate novel ways to treat haematological malignancies, with a particular focus on lymphoma and multiple myeloma. By determining the molecular mechanisms underpinning specific blood cancers, we are developing novel therapeutic strategies for translation into clinical trials. Our location within the Monash Health Translation Precinct uniquely places the laboratory in a position to develop our scientific discoveries from bench to bedside.
Major themes include, oncogenic transcription, epigenetic therapy for lymphoma and myeloma, lymphoma genomics and rational targeting of the MYC oncogene.